For the quarter ending 2025-09-30, PMI made $1,187,000 in revenue. -$10,426,000 in net income. Net profit margin of -878.35%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Revenues | 1,187,000 | 2,131,000 | ||
| Product | 880,000 | - | ||
| Rentals | 437,000 | 707,000 | ||
| Cost of revenues | 1,317,000 | 2,258,000 | ||
| Gross loss | -130,000 | -127,000 | ||
| Research and development | 951,000 | 743,000 | ||
| Selling, general and administrative | 2,406,000 | 2,651,000 | ||
| Total operating expenses | 3,357,000 | 3,394,000 | ||
| Operating loss | -3,487,000 | -3,521,000 | ||
| Interest expense | -2,404,000 | - | ||
| Derivative loss | -4,535,000 | - | ||
| Total other expense, net | -6,939,000 | - | ||
| Loss before income taxes | -10,426,000 | -6,724,000 | ||
| Provision for income taxes | 0 | 0 | ||
| Net loss | - | -6,724,000 | ||
| Net loss | -10,426,000 | -6,724,000 | ||
| Foreign currency translation adjustments, net of tax | - | -15,000 | ||
| Undeclared series a-1 preferred dividends | 0 | - | ||
| Comprehensive loss | - | -6,739,000 | ||
| Net loss attributable to common stockholders | -10,426,000 | -7,520,000 | ||
| Net loss per sharebasic and diluted (in dollars per share) | -0.19 | - | ||
| Weighted average common shares outstandingbasic and diluted (in shares) | 54,452,140 | - | ||
Picard Medical, Inc. (PMI)
Picard Medical, Inc. (PMI)